摘要
目的汉化形成中文版护士对抗癌药物暴露风险认知问卷,并检验其信效度。方法基于国际指南,采用双人翻译-回译方法对抗癌药物暴露风险认知问卷进行汉化,并采用Delphi法对问卷进行修订和跨文化调试,选择32名肿瘤相关科室护士进行预调查,确定中文版护士对抗癌药物暴露风险认知问卷,对503名护士进行正式调查,检验中文版问卷的信效度。结果根据函询结果,中文版护士对抗癌药物暴露风险认知问卷确定了包括行为自评和健康自评2个部分,共7个维度含45个条目的内容。提取7个公因子进行探索性因子分析,累计贡献率为65.67%,问卷的条目内容效度CVI指数为0.846~1,调查水平的内容效度CVI指数为0.923,Cronbach'sα系数为0.738,重测信度为0.662。结论中文版护士对抗癌药物暴露风险认知问卷具有良好的信效度,可作为评估护士对抗癌药物职业暴露风险认知和防护水平的工具。
Objective To explore the validity and reliability of the Chinese version of the Perception of Nursing Exposed to Antineoplastic Drugs(PNEAD)questionnaire.Methods Based on the international guidelines,the PNEAD questionnaire was translated into Chinese following Brislin's model of translation and was cross-cultural adapted by a pilot study of 32 oncology nurses and Delphi method.The validity and reliability of Chinese version of PNEAD questionnaire were tested among 503 nurses.Results On the basis of the items of the source questionnaire,after two rounds of expert consultation,it was determined two parts with behavior and health self-assessment,with a total of 45 items in 7 dimensions.Seven principal components were extracted by factor analysis,the cumulative variance contribution rate was 65.67%,the content validity of the questionnaire was from 0.846 to 1,S-CVI was 0.923,Cronbach's α coefficient was 0.738,and the test-retest reliability was 0.662.Conclusion The Chinese version of PNEAD has a good reliability and validity.It can be used to measure nurses'cognition and protection level of occupational exposure risk of antineoplastic hazardous drugs in China.
作者
黄小红
伍静薇
李洋
钟晓
管玉梅
洪晓丹
李丽萍
蔡文智
HUANG Xiaohong;WU Jingwei;LI Yang;ZHONG Xiao;GUAN Yumei;HONG Xiaodan;LI Liping;CAI Wenzhi(Nursing Department,Shenzhen Longgang Central Hospital,Shenzhen 518116,China;School of Graduate,Zunyi Medical University,Zunyi 563003,China;Nursing Department,Shenzhen Hospital,Southern Medical University,Shenzhen 518110,China)
出处
《护理管理杂志》
2020年第12期854-859,共6页
Journal of Nursing Administration
基金
深圳市卫生和计划生育委员会系统重点学科建设能力提升项目(201606053)。
关键词
护士
抗癌药物
暴露风险
nurses
anticarcinogen
risk exposure
